Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...
Wall Street Journal on MSN23h
Amgen Obesity Drug Cut Weight In Closely Watched StudyA highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a ...
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare ...
Midland Daily News on MSN3h
White House rule would expand coverage of anti-obesity drugsThe Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...
Last, the administration's proposal also tries to shore up guardrails for the use of AI in health care with edits to existing ...
The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback